NanoCure gets money for dendrimer development

Jan. 27, 2004 — NanoCure Corp., an Ann Arbor, Mich., developer of a nanoscale therapeutic platform for cancer treatment, was awarded a contract from the Michigan Economic Development Corporation for $187,075 over three years, according to a news release.

null

The contract is part of $1.24 million awarded to the University of Michigan to develop a drug delivery platform based on dendrimer technology licensed by NanoCure from the university.

null

NanoCure’s portion of the award will support commercialization costs, such as developing applications for clinical testing and conducting clinical trials.

POST A COMMENT

Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.